Degradation of Soluble Amyloid β-Peptides 1–40, 1–42, and the Dutch Variant 1–40Q by Insulin Degrading Enzyme from Alzheimer Disease and Control Brains (original) (raw)
REFERENCES
Selkoe, D. J. 1994. Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Annu. Rev. Cell. Biol. 10:373–403. Google Scholar
Selkoe, D. J. 1996. Amyloid β-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271:18295–18298. Google Scholar
Levy, E., Carman M. D., Fernandez Madrid I., Power M. D., Lieberburg I., van Duinen S. G., Gererd T., Bots G. T. A. M., Luvendijk W., and Frangione B. 1990. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage. Science 248:1124–1126. Google Scholar
Mann, D. M. A. 1989. Cerebral amyloidosis, aging and Alzheimer's disease; a contribution from studies on Down's syndrome. Neurobiol. Aging 10:397–399. Google Scholar
Seubert, P., Vigo Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Sclossmacher, G., Whaley, J., Swindlehurst, C., Mc Cormack, R., Wolfert, R., Selkoe, D. J., Lieberburg, I., and Schenk, D. 1992. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359:325–327. Google Scholar
Miller, D. L., Papayannopoulos, I. A., Styles, J., Bobin, S. A., Lin, Y. Y., Biemann, K., and Iqbal K. 1993. Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch. Biochem. Biophys. 301:41–52. Google Scholar
Roher, A. E., Kasunic, T. C., Woods, A. S., Cotter, R. J., Ball, M. J., and Fridman, R. 1994. Proteolysis of Aβ peptide from Alzheimer disease brain by gelatinase A. Biochem. Biophys. Res. Commun. 205:1755–1761. Google Scholar
Naidu, A., Quon, D., and Cordell, B. 1995. β-amyloid peptide produced in vitro is degraded by proteinases released by cultured cells. J. Biol. Chem. 270:1369–1374. Google Scholar
Backstrom, J. R., Lim, G. P., Cullen, M. J., and Tokes, Z. A. 1996. Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1–40). J. Neurosci. 16:7910–7919. Google Scholar
Howell, S., Nalantoglu, J., and Crine, P. 1995. Neutral endopeptidase can hydrolyze β-amyloid (1–40) but shows no effect on β-amyloid precursor protein metabolism. Peptides 16:647–652. Google Scholar
Ladror, U. S., Snyder, S. W., Wang, G. T., Holzman, T. F., and Krafft, G. A. 1994. Cleavage at the amino and carboxyl termini of Alzheimer's amyloid-β by cathepsin D. J. Biol. Chem. 269:18422–18428. Google Scholar
Qiu, W. Q., Borth, W., Ye, Z., Haass, C., Teplow, D. B., and Selkoe, D. 1996. Degradation of amyloid β-protein by a serine protease α2-macroglobulin complex. J. Biol. Chem. 271:8443–8451. Google Scholar
Qiu, W. Q., Walsh, D. M., Ye, Z., Vekrellis, K., Zhang, J., Podlisny, M. B., Rosner, M. R., Safavi, A., Hersh, L. B., and Selkoe, D. J. 1998. Insulin-degrading enzyme regulates extracellular levels of amyloid beta protein by degradation. J. Biol. Chem. 273:32730–3278. Google Scholar
Kurochkin, I. V. and Goto, S. 1994. Alzheimer's β-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. FEBS Lett. 345:33–37. Google Scholar
Mc Dermott, J. R. and Gibson, A. M. 1997. Degradation of Alzheimer's β-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme. Neurochem. Res. 22:49–56. Google Scholar
Bernstein, H.-G., Ansorge, S., Riederer, P., Reiser, M., Frölich, L., and Bogerts, B. 1999. Insulin-degrading enzyme in the Alzheimer's disease brain: prominent localization in neurons and senile plaques. Neurosci. Lett. 263:161–164. Google Scholar
Duckworth, W. C. 1988. Insulin degradation: mechanisms, products and significance. Endocrine Rev. 9:319–345. Google Scholar
Affholter, J. A., Fried, V. A., and Roth, R. A. 1988. Human insulin-degrading enzyme shares structural and functional homologies with E. coli protease III. Science 242:1415–1418. Google Scholar
Kuo, W.-L., Montag, A. G., and Rosner, M. R. 1993. Insulin-degrading enzyme is differentially expressed and developmentally regulated in various rat tissues. Endocrinology 132:604–611. Google Scholar
Akiyama, H., Yokono, K., Shii, K., Ogawa, W., Taniguchi, H., and Baba, S. 1990. Natural regulatory mechanisms of insulin degradation enzyme. Biochem. Biophys. Res. Commun. 170: 1325–1330. Google Scholar
Misbin, R. I., Almira, E. C., Duckworth, W. C., and Mehl, T. D. 1983. Inhibition of insulin degradation by insulin-like growth factors. Endocrinology 113:1525. Google Scholar
Garcia, J. V., Gehm, B. D., and Rosner, M. R. 1989. An evolutionarily conserved enzyme degrades transforming growth factor-alpha as well as insulin. J. Cell. Biol. 109:1301–1307. Google Scholar
Müller, D., Baumeister, H., Buck, F., and Richter, D. 1991. Atrial natriuretic peptide is a high-affinity substrate for rat insulin-degrading enzyme. Eur. J. Biochem. 202:285–292. Google Scholar
Safavi, A., Miller, B. C., Cottam, L., and Hersh, L. B. 1996. Identification of gamma-endorphin-generating enzyme as insulin-degrading enzyme. Biochemistry 35:14318–14325. Google Scholar
Baumeister, H., Müller, D., Rehbein, M., and Richter, D. 1993. The rat insulin-degrading enzyme: Molecular cloning and characterization of tissue-specific transcripts. FEBS Lett. 317:250–254. Google Scholar
Soto, C., Sigurdsson, E. M., Morelli, L., Kumar, R. A., Castaño, E. M., and Frangione, B. 1998. β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer disease. Nature Med. 4:822–825. Google Scholar
Schägger, H. and von Jagow, G. 1987. Tricine-sodium dodecyl sulfate-polyacrilamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166: 368–379. Google Scholar
Shii, K., Baba, S., Yokono, K., and Roth, R. A. 1985. Covalent linkage of 125I-insulin to a cytosolic insulin-degrading enzyme. J. Biol. Chem. 260:6503–6506. Google Scholar
Morelli, L., Giambartolomei, G. H., Prat, M. I., Castaño, E. M. 1999. Internalization and resistance to degradation of Alzheimer's Aβ 1–42 at nanomolar concentrations in THP-1 human monocytic cell line. Neurosci. Lett. 262:5–8. Google Scholar
Shii, K., Yokono, K., Baba, S., and Roth, R. A. 1986. Purification and characterization of insulin-degrading enzyme from human erythrocytes. Diabetes 35:675–683. Google Scholar
Kurochkin, I. V. 1998. Amyloidogenic determinant as a sustrate recognition motif of insulin-degrading enzyme. FEBS Lett. 427:153–156. Google Scholar
Soto, C., Castaño, E. M., Frangione, B., and Inestrosa, N. C. 1995. The alfa-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation. J. Biol. Chem. 270:3063–3067. Google Scholar
Castaño, E. M., Prelli, F., Wisniewski, T., Golabek, A., Kumar, R. A., Soto, C., and Frangione, B. 1995. Fibrillogenesis of Alzheimer's amyloid β peptides and apolipoprotein E. Biochem. J. 306:599–604. Google Scholar
Hari, J., Shii, K. and Roth., R. A. 1987. In vivo association of 125I-insulin with a cytosolic insulin-degrading enzyme: detection by covalent cross-linking and immunoprecipitation with a monoclonal antibody. Endocrinology 120:829–831. Google Scholar
Gehm, B. D. and Rosner, M. R. 1991. Regulation of insulin, epidermal growth factor, and transforming growth factor-αlevels by growth factor-degrading enzymes. Endocrinology 128:1603–1610. Google Scholar
Matsas, R., Kenny, J. and Turner, A. J. 1984. The metabolism of neuropeptides. Biochem. J. 223:433–440. Google Scholar
Jarrett, J., Berger, E. P., and Lansbury, P. T. Jr. 1993. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease. Biochemistry 32:4693–4697. Google Scholar
Kuo, Y.-M., Emmerling, M. R., Vigo-Pelfrey, C., Kasunic, T. C., Kirkpatrick, J. B., Murdoch, G. H., Ball, M. J., and Roher, A. E. 1996. Water-soluble Aβ(N-40, N-42) oligomers in normal and Alzheimer disease brains. J. Biol. Chem. 271: 4077–4081. Google Scholar
Qiu, W. Q., Ye, Z., Kholodenko, D., Seubert, P., and Selkoe, D. J. 1997. Degradation of amyloid β-protein by a metalloprotease secreted by microglia and other neural and non-neural cells. J. Biol. Chem. 272:6641–6646. Google Scholar
Nordsted, C., Näslund, J., Tjemberg, L. O., Karlström, A. R., Thyberg, J., and Terenius, L. 1994. The Alzheimer Aβ peptide develops protease resistance in association with its polymerization into fibrils. J. Biol. Chem. 269:30773–30776. Google Scholar
Runyan, K., Duckworth, W. C., Kitabchi, A. E., and Huff, G. 1979. The effect on age on insulin-degrading activity in rat tissue. Diabetes 28:324–325. Google Scholar
Fergusson, J., Landon, M., Lowe, J., Dawson, S. P., Layfield, R., Hanger, D. P., and Mayer, R. J. 1996. Pathological lesions of Alzheimer's disease and dementia with Lewy bodies brains exhibit immunoreactivity to an ATPase that is a regulatory subunit of the 26S proteasome. Neurosci. Lett. 219:167–170. Google Scholar
Saido, T. C. 1998. Alzheimer's disease as proteolytic disorders: anabolism and catabolism of beta-amyloid. Neurobiol. Aging 19:S69–75. Google Scholar
Cataldo, A., Barnett, J. L., Berman, S. A., Li, J., Quarless, S., Bursztajn, S., Lippa, C., and Nixon, R. A. 1995. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system. Neuron 14:671–680. Google Scholar
Mc Dermott, J. R., Biggins, J. A., and Gibson, A. M. 1992. Human brain peptidase activity with the specificity to generate the N-terminus of the Alzheimer β-amyloid protein from its precursor. Biochem. Biophys. Res. Commun. 185:746–752. Google Scholar
Kalayar, C. and Wong, W. T. 1989. Metalloprotease inhibitors which block the differentiation of L6 myoblasts inhibit insulin degradation by the endogenous insulin-degrading enzyme. J. Biol. Chem. 264:8928–8934. Google Scholar
Duckworth, W. C., Bennett, R. G., and Hamel, F. G. 1998. Insulin degradation: progress and potential. Endocrine Rev. 19: 608–624. Google Scholar
Hamel, F. G., Bennett, R. G., and Duckworth, W. C. 1998. Regulation of multicatalytic enzyme activity by insulin and the insulin-degrading enzyme. Endocrinology 139:4061–4066. Google Scholar
Kupfer, S. R., Wilson, E. M., and French F. S. 1994 Androgen and glucocorticoid receptors interact with insulin degrading enzyme. J. Biol. Chem. 269:20622–20628. Google Scholar